Clinical trial
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With…
NCT00004500 · Windtree Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00004500 |
|---|---|
| Title | Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome |
| Official title | A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Bronchoalveolar Lavage With Lucinactant to Standard Care for the Treatment of the Meconium Aspriation Syndrome (MAS) in Newborn Infants |
| Lead sponsor | Windtree Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meconium Aspiration |
| Intervention type | Drug, Other |
| Interventions | Lucinactant, Standard Care |
| Enrollment | 69 |
| Start date | Mar 1, 2000 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2004 |
| First posted | Oct 19, 1999 |
| Last update posted | May 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: